---
$id: https://graph.org.ai/products/commodity/51171717
$type: Product
source: UNSPSC
code: "51171717"
title: "Mebiquine"
class: "51171700"
classTitle: "Antidiarrheals"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mebiquine

**UNSPSC Code**: 51171717
**Class**: [Antidiarrheals](Antidiarrheals.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antidiarrheal agent with the molecular formula C10H10BiNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DBE10Q8QF6, chemically known as quinoline, 8-((dihydroxybismuthino)oxy)-6-methyl- but generally known as mebiquine, which bears US NIH Compound Identifier 16683098. European Medicines Agency schedules Mebiquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08665MIG. The term MEBIQUINE is an International Non-Proprietary Name. MEBIQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mebiquine under HS 29334990 and SITC 51575. As of Q4 2014, MEBIQUINE remains the US FDA Preferred Term for this commodity. Mebiquine bears US NLM identifiers UMLS ID C1881637 and NCI Concept Code C66060. SMILES: CC1=CC(=C2C(=C1)C=CC=N2)O[BI].O.O.

